In order to deliver a personalised, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way drugeruptiondata.com uses cookies please read our 'Cookie Policy'.
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- TRADE NAME: Emflex (Merck)
- INDICATIONS: Osteoarthritis, rheumatoid arthritis, lower back pain, post-operative pain, inflammation, musculoskeletal disorders, psychoses
- SYNONYM: acemetacine; acemetacinum
- CLASS: Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: <1.1 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
ACE inhibitors, Anti-coagulants, Aspirin, Beta blockers, Beta-Carotene, Diflunisal, Furosemide, Haloperidol, Lithium, Methotrexate, Potassium sparing diuretics, Probenecid, Salicylates, Thiazide diuretics, Triamterene, Warfarin - PREGNANCY: Contra-indicated in the third trimester of pregnancy
- See adverse reactions attributed to class:
Inhibition of platelet aggregation may occur. Aggravation of psychiatric disorders, epilepsy or Parkinsonism may occur. Patients receiving long-term treatment should be periodically screened for renal and hepatic function and blood counts.
Please login to view the rest of this drug profile.
Page last updated 08/07/2024
